Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUROPA: Switching TDF+ddI to Abacavir-based Regimens in HIV
NCT00338390Phase 3Completed
- Sponsor
- Hospital General de Granollers
- Start
- Apr 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by Hospital General de Granollers. Started Apr 2005; status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00338390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338390.